文献速递瓣膜病与结构性心脏病心力衰竭与心肌病

中度主动脉瓣狭窄合并左室收缩功能不全的预后意义

Prognostic Implications of Moderate Aortic Stenosis in Patients With Left Ventricular Systolic Dysfunction.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

本研究回顾性分析4家学术机构2010-2015年间305例中度主动脉瓣狭窄合并左室收缩功能不全(LVEF<50%)患者,主要终点为全因死亡、主动脉瓣置换和心衰住院的复合终点。4年随访时复合终点发生率为61%,全因死亡或心衰住院复合终点为48%,全因死亡36%,心衰住院27%,主动脉瓣置换24%。主要预测因素包括男性、NYHA III/IV级和峰值主动脉射流速度。

要点

  • 中度AS合并LV收缩功能不全患者4年复合终点(死亡、AVR、心衰住院)发生率高达61%。
  • 4年全因死亡或心衰住院复合终点为48%,全因死亡36%,心衰住院27%,AVR仅24%。
  • 男性、NYHA III/IV级和峰值主动脉射流速度是主要终点的独立预测因素。

核心结论

  • 中度AS合并左室收缩功能不全患者临床事件风险高,需进一步研究评估早期AVR能否改善预后。

研究设计与样本

  • 回顾性分析4家大型学术机构2010-2015年间305例中度AS(主动脉瓣面积1.0-1.5 cm²)合并左室收缩功能不全(LVEF<50%)患者的超声心动图和临床数据。

主要发现

  • 4年随访时主要复合终点(全因死亡、AVR、心衰住院)发生率为61%。
  • 4年全因死亡或心衰住院复合终点发生率为48%,全因死亡率为36%,心衰住院率为27%,AVR发生率为24%。
  • 主要终点预测因素包括男性(p=0.022)、NYHA III或IV级(p<0.001)和峰值主动脉射流速度(p<0.001)。

关键数值与推荐

  • 中度AS定义为主动脉瓣面积1.0-1.5 cm²,左室收缩功能不全定义为LVEF<50%。
  • 主要终点为全因死亡、AVR和心衰住院的复合终点。

临床怎么用

  • 对于中度AS合并左室收缩功能不全患者,应认识到其高事件风险,但早期AVR的获益尚需进一步研究确定。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Left ventricular (LV) systolic dysfunction and moderate aortic stenosis (AS) are more frequent with advancing age and often coexist. Afterload reduction is the mainstay of pharmacological treatment of heart failure (HF). Aortic valve replacement (AVR) is only formally indicated for symptomatic severe AS. OBJECTIVES: This study sought to determine the clinical outcome of patients with concomitant moderate AS and LV systolic dysfunction. METHODS: Echocardiographic and clinical data of patients with moderate AS and LV systolic dysfunction between 2010 and 2015 from 4 large academic institutions were retrospectively analyzed. Moderate AS was defined as aortic valve area between 1.0 and 1.5 cm2 and LV systolic dysfunction defined as LV ejection fraction <50%. The primary endpoint was a composite of all-cause death, AVR, and HF hospitalization. RESULTS: A total of 305 patients (mean age 73 ± 11 years; 75% male) were included. The majority were symptomatic at the time of index echocardiogram (New York Heart Association [NYHA] functional class II: 42%; NYHA functional class III: 28%; and NYHA functional class IV: 4%). Ischemic heart disease was present in 72% of patients. At 4-year follow-up, the primary composite endpoint occurred in 61%. The main predictors for the primary endpoint were male sex (p = 0.022), NYHA functional class III or IV (p < 0.001), and peak aortic jet velocity (p < 0.001). The rate of the composite of all-cause death or HF hospitalization was 48%, rate of all-cause death was 36%, and rate of HF hospitalization was 27%. AVR occurred in 24% of patients. CONCLUSIONS: Patients with concomitant moderate AS and LV systolic dysfunction are at high risk for clinical events. Further studies are needed to determine if earlier AVR in these patients might improve clinical outcome.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. van Gils L, Clavel MA, Vollema EM, et al. Prognostic Implications of Moderate Aortic Stenosis in Patients With Left Ventricular Systolic Dysfunction. J Am Coll Cardiol. 2017. PMID: 28494976. doi:10.1016/j.jacc.2017.03.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。